We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Improving Compliance With Metformin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00018616
Recruitment Status : Completed
First Posted : July 5, 2001
Last Update Posted : September 23, 2009
Information provided by:

Study Description
Brief Summary:
This is a randomized controlled trial of adherence. The study involves monitoring and managing focused intervention in patients prescribed metformin.

Condition or disease Intervention/treatment Phase
Diabetes Behavioral: MEMS caps Phase 2

Detailed Description:
The active intervention, MEMS Feedback, involves review of patients' medication-taking over the preceding weeks

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 79 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: Improving Compliance With Metformin
Study Start Date : October 1999
Primary Completion Date : January 2004
Study Completion Date : January 2005

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
1 Behavioral: MEMS caps

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Metformin has been prescribed
  • Willing to use medication containers with MEMS caps
  • Capable of giving informed consent

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00018616

United States, Connecticut
VA Connecticut Health Care System (West Haven)
West Haven, Connecticut, United States, 06516
Sponsors and Collaborators
VA Office of Research and Development
Principal Investigator: Marc I. Rosen, MD VA Connecticut Health Care System (West Haven)
More Information

Responsible Party: Rosen, Marc - Principal Investigator, Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00018616     History of Changes
Other Study ID Numbers: MHBS-047-98F
First Posted: July 5, 2001    Key Record Dates
Last Update Posted: September 23, 2009
Last Verified: September 2009

Keywords provided by VA Office of Research and Development:

Additional relevant MeSH terms:
Hypoglycemic Agents
Physiological Effects of Drugs